NCT07199309View on ClinicalTrials.gov

A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

PHASE2RecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

November 30, 2026

Conditions

Hypertriglyceridemia

Interventions

DRUG

MAR001

Subcutaneous Injection

DRUG

Placebo

Subcutaneous Injection

Trial Locations (1)

91911

RECRUITING

Marea Site 301, Chula Vista

Sponsors

Lead Sponsor

Marea Therapeutics

All Listed Sponsors

lead

Marea Therapeutics

INDUSTRY

NCT07199309 - A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol | Biotech Hunter | Biotech Hunter